INAMDAR AMIR enters HELUS PHARMA INC. with 227.82K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 10/26/2026ACC: 0000912282-26-001388
227.82K
Baseline shares
2% direct
3.49K
Direct ownership
1 position
66.67K
Derivative underlying
1 instrument
2
Security positions
224.33K indirect
Non-Derivative Holdings2
Common Shares
IndirectShares owned224.33K
Common Shares
DirectShares owned3.49K
Total
3.49K direct·224.33K indirect227.82K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 224.33K | Indirect |
| Common Shares | 3.49K | Direct |
| Total | 227.82K | 3.49K direct·224.33K indirect |
Derivative Holdings1
Restricted Share Units
IndirectUnderlying security
Common Shares
Underlying shares
66.67K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
66.67K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Restricted Share Units Indirect | Common Shares | — | — | 66.67K | N/A | |
| Total | 66.67K | 0.00 | ||||